What is the catalog number for HE4/WFDC2 Rabbit Polyclonal Antibody?

The catalog number for HE4/WFDC2 Rabbit Polyclonal Antibody is orb371697.

What sizes are available for HE4/WFDC2 Rabbit Polyclonal Antibody?

HE4/WFDC2 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is HE4/WFDC2 Rabbit Polyclonal Antibody in stock?

HE4/WFDC2 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

HE4/WFDC2 Rabbit Polyclonal Antibody

Anti-HE4/WFDC2 Antibody. Tested in ELISA, WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

WAP four-disulfide core domain protein 2; Epididymal secretory protein E4; Major epididymis-specific protein E4; Putative protease inhibitor WAP5; WFDC2; HE4, WAP5

UniProt

Q14508

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E. coli-derived human HE4 recombinant protein (Position: E31-F124) . Human HE4 shares 40.4% and 68% amino acid (aa) sequence identity with mouse and rat HE4, respectively.

Target

WAP four-disulfide core domain protein 2

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Disease Biomarkers

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

ELISA, 0.1-0.5μg/ml, - Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

25 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ELISA, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.